Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Human Molecular Genetics
|
January 9, 2026
Identification of KHDC1L, a DUX4-regulated protein, as a novel plasma biomarker in facioscapulohumeral muscular dystrophy
Nicholas A Sutliff, Emily Chao, Sean R Bennett, et al.
Molecular Cell
|
October 16, 2012
Gravin is a transitory effector of polo-like kinase 1 during cell division
David A Canton, C Dirk Keene, Katie Swinney, et al.
Immunotherapy
|
October 25, 2017
Melanoma treatment with intratumoral electroporation of tavokinogene telseplasmid (pIL-12, tavokinogene telseplasmid)
David A Canton, Shawna Shirley, Jocelyn Wright, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 15, 2012
Gravin orchestrates protein kinase A and β2-adrenergic receptor signaling critical for synaptic plasticity and memory
Robbert Havekes, David A Canton, Alan J Park, et al.
Molecular Therapy Oncolytics
|
May 20, 2022
Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity
Jack Y Lee, Bianca Nguyen, Anandaroop Mukhopadhyay, et al.
Molecular Cancer Research : MCR
|
March 18, 2022
Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity
Mia Han, Bianca Nguyen, Jack Y Lee, et al.
Molecular Cancer Therapeutics
|
June 22, 2016
ST-11: A New Brain-Penetrant Microtubule-Destabilizing Agent with Therapeutic Potential for Glioblastoma Multiforme
Allison E Cherry, Brian R Haas, Alipi V Naydenov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2024
Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma
Ahmad A Tarhini, Zeynep Eroglu, Islam Eljilany, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2021
Intratumoral Plasmid IL12 Expands CD8<sup>+</sup> T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy
Melinda L Telli, Hiroshi Nagata, Irene Wapnir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2020
Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma
Alain P Algazi, Christopher G Twitty, Katy K Tsai, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Human Molecular Genetics
|
January 9, 2026
Identification of KHDC1L, a DUX4-regulated protein, as a novel plasma biomarker in facioscapulohumeral muscular dystrophy
Nicholas A Sutliff, Emily Chao, Sean R Bennett, et al.
Molecular Cell
|
October 16, 2012
Gravin is a transitory effector of polo-like kinase 1 during cell division
David A Canton, C Dirk Keene, Katie Swinney, et al.
Immunotherapy
|
October 25, 2017
Melanoma treatment with intratumoral electroporation of tavokinogene telseplasmid (pIL-12, tavokinogene telseplasmid)
David A Canton, Shawna Shirley, Jocelyn Wright, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 15, 2012
Gravin orchestrates protein kinase A and β2-adrenergic receptor signaling critical for synaptic plasticity and memory
Robbert Havekes, David A Canton, Alan J Park, et al.
Molecular Therapy Oncolytics
|
May 20, 2022
Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity
Jack Y Lee, Bianca Nguyen, Anandaroop Mukhopadhyay, et al.
Molecular Cancer Research : MCR
|
March 18, 2022
Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity
Mia Han, Bianca Nguyen, Jack Y Lee, et al.
Molecular Cancer Therapeutics
|
June 22, 2016
ST-11: A New Brain-Penetrant Microtubule-Destabilizing Agent with Therapeutic Potential for Glioblastoma Multiforme
Allison E Cherry, Brian R Haas, Alipi V Naydenov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2024
Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma
Ahmad A Tarhini, Zeynep Eroglu, Islam Eljilany, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2021
Intratumoral Plasmid IL12 Expands CD8<sup>+</sup> T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy
Melinda L Telli, Hiroshi Nagata, Irene Wapnir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2020
Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma
Alain P Algazi, Christopher G Twitty, Katy K Tsai, et al.
Page
of 2